Calcimimetics in peritoneal dialysis patients.

Piergiorgio Messa,Claudia Castelnovo,A. Scalamogna

Calcimimetics in peritoneal dialysis patients.

2012

Piergiorgio Messa
Claudia Castelnovo
A. Scalamogna

Though the prevalence of secondary hyperparathyroidism (SHP) and the related mineral metabolism (MM) changes have been reported at almost the same rate in peritoneal dialysis (PD) as in hemodialysis (

Keywords:

Intensive care medicine
Medicine
Diabetes mellitus
Secondary hyperparathyroidism
Hemodialysis
Peritoneal dialysis
mineral metabolism
Gastroenterology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations